Study, Commentary Examine XDR-TB Treatment Outcomes In S. Africa

A post in the Center for Global Health Policy’s “Science Speaks” blog discusses a study and commentary published last week in The Lancet that evaluated the long-term outcomes of extensively drug-resistant tuberculosis (XDR-TB) patients in South Africa. “…Both the report and commentary call for policymakers and national control programs to urgently develop strategies to use existing public health instruments for TB control. They also argue for community-based interventions and the creation of palliative care facilities to minimize disease spread by patients who fail treatment” (Aziz, 4/7).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.